BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
BNB$577.36-1.84%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
BNB$577.36-1.84%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
The latest earnings reports from T-Mobile, Kraft Heinz, and Humana reveal diverse performances and strategic focuses across different industries.
Humana stock fell more than 13% in premarket trading after the Trump administration proposed nearly flat Medicare Advantage payment rates for 2027.
Humana’s third-quarter results beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion, as the company reaffirmed its full-year EPS guidance.
Humana Inc. reports second quarter 2025 financial results with earnings per share (EPS) slightly below expectations.
Humana Inc. reports a strong first quarter of 2025 with adj. EPS exceeding expectations,
The decision to raise Medicare Advantage plan payments by over $25 billion has led to a positive response in the stock market.
Humana Inc. reported a net loss per share of $5.76 on a GAAP basis and an adjusted net loss per share of $2.16 for the fourth…
Cigna Group has decided not to merge with Humana, leading to a rise in Cigna's stock and a drop in Humana's stock.
Humana Inc. (NYSE: HUM) reported a strong third quarter in 2024, with GAAP earnings per share hitting $3.98 and adjusted EPS at $4.16.
Major stocks Tesla, Nike, and Humana face significant declines as Tesla misses delivery expectations, Nike withdraws guidance amid a CEO change, and Humana's Medicare quality ratings…
In a volatile trading session, Nike shares plunged nearly 20% following disappointing sales forecasts, while healthcare stocks Humana and UnitedHealth saw gains.
Humana withdrew its 2025 guidance due to Medicare Advantage uncertainties. Stock dropped over 5%.